EMA
withdrawal
· 2023-05-04
EMA Withdrawn: NeuroBloc (botulinum toxin type B) — Sloan Pharma S.a.r.l
Summary
EMA withdrew NeuroBloc (botulinum toxin type B) from the market for the treatment of torticollis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Status: Withdrawn. Therapeutic area: Torticollis. MAH: Sloan Pharma S.a.r.l. Decision date: 04/03/2021